Neuromodulation

Global Market Trajectory & Analytics

MCP13576

EXECUTIVE ENGAGEMENTS

POOL

10472
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1256
Interactions with Platform & by Email

PARTICIPANTS

314
Unique # Participated

VALIDATIONS

76
Responses Validated*

COMPANIES

83
Responses Validated*
* Login for a full stack data experience

DATE

MAY 2021

TABLES

120

PAGES

298

EDITION

8

PRICE

USD 4950

CODE

MCP13576


COMPETITIVE METRICS

COMPANY

D S N T

% *

Abbott Laboratories, Inc.

Aleva Neurotherapeutics SA

Atlantic Therapeutics Group Limited

Axonics Modulation Technologies, Inc.

B. Braun Melsungen AG

Beijing Pins Medical Co., Ltd.

Biegler GmbH

BioControl Medical Ltd.

Bioinduction

Bio-Medical Research Limited

*Login to Participate & View Data Stacks
View 83 Companies...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Global Neuromodulation Market to Reach $8.2 Billion by 2026

Neuromodulation functions through the active stimulation of the nerves to generate a biological reaction or through the direct application of targeted pharmaceutical agents in small doses to the area of action. Neurostimulation devices work by applying electrodes to the spinal cord, brain, or to the peripheral nerves. Growth in the global market is being fueled by the expanding base of people suffering from various illnesses such as urinary incontinence, Parkinson`s disease, spinal cord damage, migraine, and epilepsy. The market is also expected to gain from the rising awareness regarding neurodegenerative and neurological disorders, and expanding application areas. The rising incidence of depression and its associated symptoms, especially among millennials, opens up new opportunities. Furthermore, increasing aging population globally, and growing awareness of the efficacy and safety of neurostimulator devices are aiding market growth.

Amid the COVID-19 crisis, the global market for Neuromodulation estimated at US$5.1 Billion in the year 2020, is projected to reach a revised size of US$8.2 Billion by 2026, growing at a CAGR of 8.2% over the analysis period. Spinal Cord Stimulation, one of the segments analyzed in the report, is projected to grow at a 8.3% CAGR to reach US$3.9 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Deep Brain Stimulation segment is readjusted to a revised 8.6% CAGR for the next 7-year period. This segment currently accounts for a 16.7% share of the global Neuromodulation market. Spinal Cord Stimulation (SCS) segment is making robust gains, driven by widespread availability of a broad range of commercial SCS products and the expanding range of applications for these devices. SCS systems are used in neurological problems such as arachnoiditis, neuropathy, neuritis, nerve damage, problems related to failed-back surgery, and complex regional pain syndrome. Deep brain stimulation is expected to register considerable growth, owing to its use in the treatment of various neurological conditions such as depression, tremor, Parkinson`s disease, and others. DBS technique is already approved by the US FDA for treating obsessive-compulsive disorder, dystonia, essential tremor, epilepsy, and Parkinson`s disease.

The U.S. Market is Estimated at $2.6 Billion in 2021, While China is Forecast to Reach $597.6 Million by 2026

The Neuromodulation market in the U.S. is estimated at US$2.6 Billion in the year 2021. The country currently accounts for a 48.43% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$597.6 Million in the year 2026 trailing a CAGR of 10% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.9% and 8.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR while Rest of European market (as defined in the study) will reach US$663.5 Million by the end of the analysis period. The US represents the leading regional market, fueled by technological advancements and significant investments made by leading companies for product development. Besides the increasing incidence of neurological diseases and expanding geriatric population, increasing spending on healthcare sector, positive reimbursement framework and presence of several leading industry players in the region are fueling market growth. Highly developed healthcare infrastructure, increased prevalence of diseases and growing approvals for non-invasive devices in Europe have been adding to the demand for these devices. Growth in the Asia-Pacific region is supported by significant prevalence of neurological disorders, the research activities underway, growing investments by private and public players, and increasing initiatives for improving awareness about mental health.

Sacral Nerve Stimulation Segment to Reach $1.2 Billion by 2026

In the global Sacral Nerve Stimulation segment, USA, Canada, Japan, China and Europe will drive the 7.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$696.3 Million in the year 2020 will reach a projected size of US$1.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$70.2 Million by the year 2026.

SELECT PLAYERS

Abbott Laboratories; Aleva Neurotherapeutics SA; BioControl Medical; Bioness Inc; Boston Scientific Corporation; Cefaly; electroCore, Inc.; Inspire Medical Systems, Inc.; LivaNova PLC; Medtronic; Neuronetics; NeuroPace, Inc.; NeuroSigma, Inc.; Nevro Corporation; Respicardia, Inc; Stimwave LLC; Synapse Biomedical, Inc.

SEGMENTS

» Technology (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation, Other Technologies) » Application (Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine, Other Applications)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Neurological Disorders
A Prelude to Neuromodulation
Indications for Neuromodulation Therapy
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
EXHIBIT: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
Global Neuromodulation Market Buckles under COVID-19 Strain
Effects of COVID-19 on the Nervous System Sheds Focus on Neuromodulation Applications
GLOBAL MARKET OVERVIEW
Neuromodulation Market Set for a Robust Growth
Neuromodulation Market by Segment
Spinal Cord Stimulation (SCS) and Deep Brain Stimulation (DBS) Represents the Largest Segments
Neuromodulation Devices by Technology
Spinal Cord Stimulation Market (2020): Dollar Market Share of Leading Players in Percentage
Neuromodulation Market by Application
Growing Clinical Applications to Drive Demand
US and Europe Dominate the Market
Asia-Pacific and other Emerging Regions Display Impressive Growth Potential
Competition
Select FDA Approved Neuromodulation Devices in Recent Years
Recent Market Activity
Market Restraints and Challenges
WORLD BRANDS
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
High Incidence of Neurological Disorders: A Key Market Driver
Annual Incidence of Adult-Onset Neurologic Disorders in the US
Rising Geriatric Population and Subsequent Growth in Prevalence of Neurological Disorders
EXHIBIT 3: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices
EXHIBIT 4: Global Alzheimer's Prevalence by Age Group
EXHIBIT 5: Diagnosed Prevalence Cases of Parkinson’s Disease Across Select Countries
EXHIBIT: Global DBS Market by Leading Player (2020E): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott
Select Available Deep Brain Stimulation Devices Available in the Market
Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices
EXHIBIT 7: Epilepsy Incidence by Type (2019): Percentage Share Breakdown for Idiopathic and Symptomatic Epilepsy
EXHIBIT 8: Symptomatic Epilepsy Incidence by Type (2019): Percentage Share Breakdown of Congenital, Degenerative, Infective, Neoplastic, Trauma, and Vascular Epilepsy
Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
Recent Developments in Spinal Cord Injury Treatment
TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth
Non-Invasiveness of TMS (Transcranial Magnetic Stimulation) Propelling the adoption of TMS devices
Neuromodulation Technologies to Gain Preference Over Opioids
Tibial Neuromodulation to Impact Overactive Bladder Market
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Neuromodulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Neuromodulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Neuromodulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Spinal Cord Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Sacral Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Transcutaneous Electrical Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Transcutaneous Electrical Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Transcutaneous Electrical Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Repetitive Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Repetitive Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Repetitive Transcranial Magnetic Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Chronic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Failed Back Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Failed Back Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Failed Back Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Parkinson`s Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Parkinson`s Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Parkinson`s Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2012, 2020 & 2027
China Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Neuromodulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Neuromodulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Neuromodulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2012, 2020 & 2027
France Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Neuromodulation by Technology - Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Neuromodulation by Technology - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation and Other Technologies for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Neuromodulation by Application - Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Neuromodulation by Application - Percentage Breakdown of Value Sales for Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine and Other Applications for the Years 2012, 2020 & 2027
Total Companies Profiled: 83

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com